Showing 5,981 - 6,000 results of 60,155 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 0.70s Refine Results
  1. 5981

    Ligand-Controlled Magnetic Interactions in Mn<sub>4</sub> Clusters by Erik Kampert (2330428)

    Published 2009
    “…Experimentally measured magnetic moments in high magnetic fields show that, upon electron density withdrawal, the main antiferromagnetic exchange constant <i>J</i><sub>1</sub> decreases from −2.2 K for the [Mn<sub>4</sub>(OAc)<sub>4</sub>] cluster to −1.9 K for the [Mn<sub>4</sub>(H<sub>5</sub>C<sub>6</sub>COO)<sub>4</sub>] cluster and −0.6 K for the [Mn<sub>4</sub>(F<sub>3</sub>CCOO)<sub>4</sub>] cluster, while <i>J</i><sub>2</sub> decreases from −1.1 K to nearly 0 K and <i>J</i><sub>3</sub> changes to a small ferromagnetic coupling. …”
  2. 5982

    Data_Sheet_5_Identification of the Type IX Secretion System Component, PorV (CHU_3238), Involved in Secretion and Localization of Proteins in Cytophaga hutchinsonii.PDF by Dong Zhao (217545)

    Published 2021
    “…The type IX secretion system (T9SS) is involved in protein secretion and gliding motility, which is unique to the phylum Bacteroidetes. In this study, we deleted a homologous gene of PorV (chu_3238), a shuttle protein in the T9SS. …”
  3. 5983
  4. 5984
  5. 5985
  6. 5986

    Model parameter bounds for optimization. by Hélder Seixas Lima (18840636)

    Published 2024
    “…<div><p>Our study conducts a comprehensive analysis of the Covid-19 pandemic in Brazil, spanning five waves over three years. We employed a novel Susceptible-Infected-Recovered-Dead-Susceptible (SIRDS) model with a fuzzy transition between epidemic periods to estimate time-varying parameters and evaluate case underreporting. …”
  7. 5987

    Summary of Covid-19 data in Brazil (2020–2022). by Hélder Seixas Lima (18840636)

    Published 2024
    “…<div><p>Our study conducts a comprehensive analysis of the Covid-19 pandemic in Brazil, spanning five waves over three years. We employed a novel Susceptible-Infected-Recovered-Dead-Susceptible (SIRDS) model with a fuzzy transition between epidemic periods to estimate time-varying parameters and evaluate case underreporting. …”
  8. 5988
  9. 5989
  10. 5990

    Comparison of antibody persistency through one year between one-dose and two-dose regimens of Ad5-nCoV vaccine for COVID-19 by Jia-Lu Feng (16520451)

    Published 2023
    “…<p>This post-hoc analysis compared the receptor-binding domain (RBD)-specific and pseudovirus neutralizing antibodies against the wild-type SARS-CoV-2 strain elicited by one or two doses (56-d interval) of Ad5-nCoV vaccine regimen (NCT04341389 and NCT04566770). …”
  11. 5991
  12. 5992
  13. 5993
  14. 5994

    Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury by Fengming Huang (8582019)

    Published 2020
    “…Using high-throughput RNA sequencing, we identified a total of 1,233 genes differentially expressed in A549 cells upon H5N1 virus infection. …”
  15. 5995
  16. 5996

    PowerPoint Slides for: Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy by Hwang J.H. (3300987)

    Published 2016
    “…Histologically, group 3 patients were correlated with severe interstitial fibrosis/tubular atrophy (p = 0.004), interstitial inflammation (p = 0.007), hyaline arteriolosclerosis (p = 0.001) and glomerular sclerosis (p < 0.001). A higher initial uPOSTN/Cr level was associated with a greater decline in eGFR during follow-up (p = 0.043 when initial eGFR ≥60; p = 0.025 when eGFR <60 ml/min/1.73 m2), and the renal outcomes with end-stage renal disease (ESRD; p = 0.003), ESRD and/or eGFR decrease of >30% (p = 0.033) and ESRD and/or eGFR decrease of >50% (p = 0.046) occurred significantly more in group 3. …”
  17. 5997

    Image_2_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpeg by Jae Hong Choi (3339120)

    Published 2022
    “…Background<p>Effective vaccines against coronavirus disease 2019 (COVID-19) are available worldwide; however, the longevity of vaccine effectiveness is not known.</p>Objective<p>We performed a prospective observational study to assess the antibody response of healthcare workers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after BNT162b2 mRNA COVID-19 vaccination.…”
  18. 5998

    Image_1_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpg by Jae Hong Choi (3339120)

    Published 2022
    “…Background<p>Effective vaccines against coronavirus disease 2019 (COVID-19) are available worldwide; however, the longevity of vaccine effectiveness is not known.</p>Objective<p>We performed a prospective observational study to assess the antibody response of healthcare workers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after BNT162b2 mRNA COVID-19 vaccination.…”
  19. 5999
  20. 6000